Andrew Marion, Jeff Whitmore | GenomeWeb
Biomarker diagnostics developer Singulex has added Andrew Marion to its board of directors, the company said last week.
 
Marion is the founder of Applied Biosystems. He is currently a director at Molecular Devices, Applied Imaging, Alpha M.O.S., and Guava Technologies.
 
He was CEO at ABI for seven years and was chairman of the board for six, after which he served as vice president at PerkinElmer.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.